文摘
A scaleable route to 6-chloro-4-[2-(3-fluoropyridin-2-yl)-imidazol-1-ylmethyl]-5-propyl-pyrimidine (NDT 9533750), a keyintermediate to a series of novel subtype preferring GABAApartial agonists, is described in which various scaleup issueswere addressed to provide an efficient and robust route for thepreparation of kilogram quantities of the compound.